Comparison of thallium-201 and gallium-67 scintigraphy in the evaluation of non-Hodgkin's lymphoma

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 1, 1998, Pages 33-38

  Roach, P J ^a   Cooper, R A ^a,b   Arthur, C K ^a   Ravich, R B ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Gallium 67; Lymphoma; Thallium 201

Indexed keywords

GALLIUM 67; THALLIUM 201;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NONHODGKIN LYMPHOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR SCINTISCANNING;

EID: 0031913091     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb04456.x     Document Type: Article

References (36)

1. McLaughlin AF, Magee MA, Greenough R et al. Current role of gallium scanning in the management of lymphoma. Eur J Nucl Med 1990; 16: 755-71.
2. Bakshi S, Bender MA. Use of gallium-67 scanning in the management of lymphoma. J Surg Oncol 1973; 5: 539-49.
3. Weeks JC, Year JC, Canellos GP et al. Value of follow-up procedures in patients with large cell lymphoma who achieve a complete remission. J Clin Oncol 1991; 9: 1196-203.
4. Kaplan WD, Jochelson MS, Herman TS et al. Gallium-67 imaging: a predictor of residual tumour viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol 1990; 8: 1966-70.
5. Scott AM, Larson SM. Tumor imaging and therapy. Radiol Clin North Am 1993; 31: 859-79.
6. Front D, Israel O, Epelbaum R et al. Ga-67 SPECT before and after treatment of lymphoma. Radiology 1990; 175: 515-9.
7. Tumeh SS, Rosenthal DS, Kaplan WD et al. Lymphoma: Evaluation with Ga-67 SPECT. Radiology 1987; 164: 111-4.
8. Waxman AD, Eller D, Ashook G et al. Comparison of gallium-67 citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. J Nucl Med 1996; 37: 46-50.
9. Kaplan WD, Southee AE, Annese ML et al. Evaluating low and intermediate grade non-Hodgkin's lymphoma with gallium-67 and thallium-201 imaging (Abstr.). J Nucl Med 1990; 31: 793.
10. Mansberg R, Fernandes VB, Mansberg VJ, Rossleigh MR. Thallium-201 and Gallium-67 scintigraphy in non-Hodgkin's lymphoma. Aust NZ J Med 1996; 26: 731 (Abstr.).
11. Bentley M, Taylor K. Low grade non-Hodgkin's lymphoma - biology and therapeutic approaches. Aust NZ J Med 1997; 27: 150-5.
12. NCI sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 47: 201-14.
13. Hagemeister FB, Fesus SM, Lamki LM et al. Role of the gallium scan in Hodgkin's disease. Cancer 1990; 65: 1090-6.
14. Kaplan WD. (Editorial). Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative? J Nucl Med 1990; 31: 369-71.
15. Wylie BR, Southee A, Joshua DE et al. Gallium scanning in the management of mediastinal Hodgkin's disease. Eur J Haematol 1989; 42: 344-7.
16. Kostakoglu L, Yeh SDJ, Portlock C et al. Validation of gallium-67-citrate single photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 1992; 33: 345-50.
17. Waxman AD. Thallium-201 in nuclear oncology. In: Freeman LM. Nuclear Medicine Annual. New York: Raven Press, 1991; 193-209.
18. Salvatore M, Carratii L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976; 21: 487-8.
19. Tonami N, Hisada K. Clinical experience of tumor imaging with thallium-201-chloride. Clin Nucl Med 1977; 2: 75-81.
20. Hisada K, Tonami H, Miyamae T et al. Clinical evaluation of tumor imaging with thallium-201-chloride. Radiology 1978; 129: 497-500.
21. Tonami N, Hisada K. Thallium-201 scintigraphy in post-operative detection of thyroid cancer; a comparative study with 131-1. Radiology 1980; 136: 461-4.
22. Stoller DW, Waxman AD, Rosen G et al. Comparison of thallium-201, gallium-67, technetium-99m ADP and magnetic resonance imaging of musculoskeletal sarcoma (Abstr.). Clin Nucl Med 1986; 12 (Suppl.): 15.
23. Kaplan WD, Takvorian T, Morris JH et al. Thallium-201 brain tumour imaging: a comparative study with pathological correlation. J Nucl Med 1987; 28: 47-52.
24. Hofnagel CA, Delprat CC, Marcus HR et al. Role of thallium-201 total body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 1988; 27: 1854-7.
25. Lee VW, Rosen MP, Baum A, Cohen SE, Cooley T, Liebman HA. AIDS-related Kaposi sarcoma: findings on thallium-201 scintigraphy. AJR 1988; 151: 1233-5.
26. Sehweil AM, McKillop JH, Milroy R et al. Thallium-201 scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Comm 1990; 11: 263-9.
27. Tonami N, Shuke N, Kunihiko Y et al. Use of thallium-201 single-photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30: 997-1004.
28. Ramanna L, Waxman AD, Braunstein G. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determination. J Nucl Med 1991; 32: 441-6.
29. Waxman AD, Ramanna L, Memsic LD et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34: 18-23.
30. Ramanna L, Waxman AD, Binney G et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in evaluation of chemotherapy response. J Nucl Med 1990; 31: 567-72.
31. Roach PJ, Janicek MJ, Kaplan WD. Bone lymphoma: comparison of Tl-201 and Ga-67 scintigraphy. Clin Nucl Med 1996; 9: 689-93.
32. Gehring PJ, Hammand PB. The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther 1967; 155: 187-201.
33. Britten JS, Blank M. Thallium activation of the (Na+, K+) activated ATPase of rabbit kidney. Biochm Biophys Acta 1968; 15: 160-6.
34. Sessler MJ, Geek P, Maul FP et al. New aspects of cellular thallium uptake Tl+-Na+-2Cl(-)-Co-transport is the central mechanism of ion uptake. J Nucl Med 1986; 25: 24-7.
35. Winzelberg GG, Melada GA, Hydrovitz JD. False-positive thallium-201 parathyroid scan of the mediastinum in Hodgkin's lymphoma. AJR 1986; 147: 819-21.
36. Dunkley SM, Roach PJ, Hoschl R, Cooper RA, Isbister J. Thallium-201 and Gallium-65 avidity in an intermediate grade T cell non-Hodgkin's disease. Aust NZ J Med 1996; 36: 725-6.